Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07839884

A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time

Conditions: Moderate to Severe Chronic Obstructive Pulmonary Disease

Sex: All
Ages: 35 Years – 80 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 1360
Sponsor: Pfizer

Summary

A Continuation Study of Tilrekimig in Adults with Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About this Medicine when Used for a Long Period of Time.

Eligibility Criteria

INCLUSION CRITERIA * Participants who completed parent study C4531031. * Individuals of childbearing potential must be willing to use a highly effective method of contraception. EXCLUSION CRITERIA * Ongoing safety-significant AE. * Parent-study SAE incompatible with continued participation. * Medical, laboratory, psychiatric, or behavioral condition that increases risk or interferes with study participation. * Pregnancy or breastfeeding.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07839884). StuddyBuddy aggregates publicly available trial information.